SCHEMBL12606765

SCHEMBL12606765

CC(C)(C)OC(=O)N[C@H]1CCCCCCC(F)(F)CC[C@@H](C(=O)C(=O)NC2CC2)NC(=O)[C@@H]2[C@@H]3[C@H](CN2C1=O)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12608096 0.97 — —
SCHEMBL12608016 0.97 — —
SCHEMBL12608010 0.97 GAA (0.31) —
SCHEMBL8290536 0.92 GAA (0.33) —
SCHEMBL16349821 0.92 GAA (0.31) —
SCHEMBL13685751 0.91 F2 (0.32) —
SCHEMBL8056985 0.87 BACE1 (0.31) —
SCHEMBL12607510 0.86 — —
SCHEMBL12606433 0.85 — —
SCHEMBL13685678 0.84 GAA (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback